(ARRY) Array Biopharma complete technical analysis [charts+indicators] | Buy/Sell Array Biopharma | (ARRY) share price targets
Complete technical analysis of Array Biopharma (ARRY) by charts plus indicators, forecast predictions and share price targets for Array Biopharma (ARRY)
Array Biopharma trades in USA in Health Care sector.
Showing technical analysis as on 2024-07-11 View latest technical analysis
10 day averaged volume of Array Biopharma is 5552930
Date | Daily Closing Price | Open | High | Low | Volume |
11 Thu Jul 2024 | 10.82 | 10.43 | 10.86 | 10.20 | 1.127 times |
10 Wed Jul 2024 | 9.90 | 9.49 | 10.06 | 9.46 | 0.845 times |
09 Tue Jul 2024 | 9.44 | 9.67 | 9.67 | 9.37 | 0.984 times |
08 Mon Jul 2024 | 9.70 | 9.72 | 9.84 | 9.52 | 0.653 times |
05 Fri Jul 2024 | 9.62 | 10.15 | 10.30 | 9.61 | 0.67 times |
03 Wed Jul 2024 | 10.11 | 9.79 | 10.20 | 9.60 | 1.059 times |
03 Wed Jul 2024 | 10.11 | 9.79 | 10.20 | 9.60 | 1.059 times |
02 Tue Jul 2024 | 9.63 | 9.57 | 10.17 | 9.34 | 1.141 times |
01 Mon Jul 2024 | 9.57 | 10.43 | 10.52 | 9.52 | 1.322 times |
28 Fri Jun 2024 | 10.26 | 10.69 | 10.85 | 10.05 | 1.549 times |
My analysis of stock is bullish for shortterm, and stock might move up till 11.9 or till 13.3. Use a stoploss of 10.8 and if this stock hits its stoploss, then it can fall down till 9.67
Share price targets for Array Biopharma (ARRY)
Target Type | Value |
Downside Target | 9.34 |
Downside Target | 9.60 |
Downside Target | 10.05 |
Downside Target | 10.30 |
Downside Target | 10.52 |
Downside Target | 10.82 |
Upside Target | 11.11 |
Upside Target | 11.38 |
Upside Target | 11.46 |
Upside Target | 12.83 |
Upside Target | 14.45 |
Upside Target | 14.85 |
Upside Target | 15.12 |
Upside Target | 15.35 |
Intraday share price targets for Array Biopharma (ARRY)
Target Type | Value |
Downside Intraday Target | 9.84 |
Downside Intraday Target | 8.86 |
Upside Intraday Target | 11.33 |
Upside Intraday Target | 11.84 |
Downside Intraday Target | 10.35 |
Weekly technical analysis of Array Biopharma (ARRY)
Date | Weekly Closing Price | Open | High | Low | Volume |
11 Thu Jul 2024 | 10.82 | 9.72 | 10.86 | 9.37 | 2.087 times |
05 Fri Jul 2024 | 9.62 | 9.79 | 10.30 | 9.60 | 0.491 times |
03 Wed Jul 2024 | 10.11 | 10.43 | 10.52 | 9.34 | 0.714 times |
28 Fri Jun 2024 | 10.26 | 11.21 | 11.46 | 10.05 | 1.945 times |
21 Fri Jun 2024 | 11.29 | 12.27 | 12.83 | 11.11 | 2.339 times |
Price has moved up this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Array Biopharma (ARRY)
Date | Monthly Closing Price | Open | High | Low | Volume |
11 Thu Jul 2024 | 10.82 | 10.43 | 10.86 | 9.34 | 0.537 times |
28 Fri Jun 2024 | 10.26 | 14.12 | 14.45 | 10.05 | 0.666 times |
31 Fri May 2024 | 14.18 | 12.38 | 14.85 | 10.60 | 1.222 times |
30 Tue Apr 2024 | 12.34 | 15.02 | 15.12 | 10.82 | 0.982 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Array Biopharma (ARRY)
Price action analysis of Array Biopharma ( (ARRY) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Array Biopharma ( (ARRY) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Array Biopharma stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Array Biopharma in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Array Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Array Biopharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Array Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 9.95 and Array Biopharma (ARRY) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Array Biopharma (ARRY) stock. Volume based technical analysis of Array Biopharma (ARRY) stock is negative.
Array Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Array Biopharma ( (ARRY) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Array Biopharma stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Array Biopharma in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Array Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Array Biopharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Array Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 9.95 and Array Biopharma (ARRY) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Array Biopharma (ARRY) stock. Volume based technical analysis of Array Biopharma (ARRY) stock is negative.
Array Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.